These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2420299)

  • 1. [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole].
    Dumoulin P; Jaillon P; Kher A; Poirier JM; Cheymol G; Valty J; Flammang D; Coumel P; Medvedowsky JL; Barnay C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():105-9. PubMed ID: 2420299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J; Klein H; Shanks RG; Bender F
    Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: relationship to plasma concentrations--a French multicenter trial.
    Dumoulin P; Jaillon P; Kher A; Poirier JM; Cheymol G; Valty J; Flammang D; Coumel P; Medvedowsky JL; Barnay C
    Am Heart J; 1985 Sep; 110(3):575-81. PubMed ID: 2412428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
    J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)].
    Kuck KH; Hanrath P; Lubda J; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1701-5. PubMed ID: 93043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encainide for cardiac arrhythmias.
    Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
    Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of encainide (MJ 9067): a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Eur J Clin Pharmacol; 1979 Nov; 16(5):323-6. PubMed ID: 93050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block.
    Schwartz AB; Shapiro WA; Suave MJ; Shen E; Bhandari A; Morady F; Scheinman M
    Can J Cardiol; 1987 Mar; 3(2):75-82. PubMed ID: 3105850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ectopic atrial arrhythmias and premature atrial complexes in adults with encainide.
    Pool PE; Quart BD
    Am J Cardiol; 1988 Dec; 62(19):60L-62L. PubMed ID: 2462340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness of barucainide in supraventriculr and ventricular arrhythmias].
    Brugger P
    Z Kardiol; 1989 Aug; 78(8):510-8. PubMed ID: 2477959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of twice daily with thrice daily administered encainide for benign or potentially lethal ventricular arrhythmias.
    Hohnloser SH; Zabel M; Zehender M; Meinertz T; Just H
    Am J Cardiol; 1989 Jan; 63(1):73-6. PubMed ID: 2462343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Pool P; Miller R; Hsu PH; Lee I; Clark DM
    Am J Cardiol; 1986 Apr; 57(10):769-74. PubMed ID: 3083665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainide.
    Harrison DC; Kates RE; Quart BD
    Am J Cardiol; 1986 Aug; 58(5):66C-73C. PubMed ID: 3092622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encainide hydrochloride and flecainide acetate: two class 1c antiarrhythmic agents.
    Chase SL; Sloskey GE
    Clin Pharm; 1987 Nov; 6(11):839-50. PubMed ID: 3119276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.